Gasdermin D-dependent macrophage pyroptosis mediates polystyrene microplastics-induced pulmonary fibrosis

Heng Liu1, Dandan Wang1, Jierui Li2

  • 1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

PubMed

Insights

Polystyrene microplastics (PS-MPs) cause lung fibrosis by triggering macrophage pyroptosis, a cell death process. Blocking GSDMD, a key protein in pyroptosis, significantly reduced fibrosis and lung damage.

Area of Science:

  • Environmental Health
  • Pulmonary Medicine
  • Cellular Biology

Background:

  • Microplastic (MP) pollution is a growing environmental concern.
  • Macrophage pyroptosis is implicated in the development of pulmonary fibrosis (PF).

Purpose of the Study:

  • To investigate the role of macrophage pyroptosis in polystyrene microplastic (PS-MP)-induced pulmonary fibrosis.
  • To elucidate the pathogenic pathway linking PS-MPs to lung fibrosis.

Main Methods:

  • A 56-day intranasal exposure model using 5-μm PS-MPs in mice.
  • Assessment of lung fibrosis, collagen deposition, extracellular matrix remodeling, and lung function.
  • Analysis of macrophage pyroptosis markers (NLRP3 inflammasome, caspase-1, GSDMD-NT).
  • Genetic ablation of Gsdmd in mice to evaluate its role in fibrosis.

Main Results:

  • Chronic PS-MP exposure induced significant pulmonary fibrosis and lung function impairment.
  • PS-MPs triggered GSDMD-dependent pyroptosis in alveolar macrophages.
  • Genetic deletion of Gsdmd attenuated fibrotic progression and reduced pro-fibrotic mediators like IL-1β.
  • Conditioned medium from pyroptotic macrophages promoted fibroblast activation and ECM production.

Conclusions:

  • PS-MPs induce pulmonary fibrosis via GSDMD-dependent macrophage pyroptosis.
  • GSDMD is a critical mediator and potential therapeutic target for microplastic-induced lung disease.
  • Findings highlight environmental health risks of MPs and suggest intervention strategies for related respiratory disorders.